Biomaterials in Skin Wound Healing and Tissue Regenerations, 3rd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 170
Special Issue Editor
Interests: diabetes; keratin biomaterials; skin wound healing; scaffolds; surgical wounds; tissue regeneration; wound dressing; biodegradability/biocompatibility; animal model of wound healing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Normal skin wound healing is a complex biological process, involving many different stages and cell types, as well as numerous signaling molecules and pathways which aim to restore skin structure and function. However, impaired wound healing is a major medical problem, especially in diabetes. The promotion of skin regeneration in cases of acute or chronic wounds through the use of tissue-engineered products is an active field of research. One of the primary goals of tissue engineering and regenerative medicine is the development of a matrix or scaffolding system that mimics the structure and function of native tissue. In the last few years, biomaterials have been widely investigated for several biomedical applications, such as implants, wound dressings, scaffolds, drug delivery systems, and antibacterial agents for regenerative medicine. These materials’ surface functionalization, achieved through incorporating biomolecules, biopolymers, or bioactive drugs, has been shown to offer improvements in the field of creating new types of wound dressings. The evolution of modern biomaterials is focused on challenges related to the design of biocompatible smart materials with desired physical, chemical, mechanical, biological, and degradation properties that match the requirements for specific medical applications.
Dr. Marek Konop
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- experimental dermatology
- tissue engineering
- controlled drug release
- nanoparticles and antibacterial properties
- biopolymers
- wound dressing
- cell and molecular biology
- molecular signaling
